The Role of Transgenic Livestock in the Treatment of Human Disease

Issue Papers - IP35 - May 2007
Download Publication

PART 6, “ANIMAL AGRICULTURE’S FUTURE THROUGH BIOTECHNOLOGY.” This paper describes the potential for transgenic livestock to advance the development of new medications for the treatment of human disease. Two techniques discussed in this paper are the predominant methods used to produce transgenic livestock, pronuclear microinjection and somatic cell nuclear transfer (SCNT). The paper offers a brief overview of current production methods and challenges and addresses economic, regulatory, and societal factors that impact the commercialization of products and treatments derived from transgenic animals. An appendix provides an in-depth description of the SCNT methodology. (Keywords: Biotechnology, GMO, transgenic)

Chair: Carol L. Keefer, University of Maryland, College Park. IP35, May 2007, 12 pp. Available free online and in print (fee for shipping/handling).

Publication Impact Report – November 2007


Task Force Chair

Carol Keefer

Task Force Author(s)

Jerry Pommer

James Robl

Task Force Reviewers

John Matheson

John Phillips

Bruce Watkins

Task Force Board Liaison

Lyle Vogel

Help Support CAST

Your donation to CAST helps support the CAST mission of communicating science to meet the challenge of producing enough food, fiber and fuel for a growing population. Every gift, no matter the size, is appreciated.